NUVO
Holdco Nuvo Group D.G Ltd. Ordinary SharesNASDAQHealthcare$0.17+0.00%ClosedMarket Cap: $5.7M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.05
P/S
32.13
EV/EBITDA
-0.50
DCF Value
$0.08
FCF Yield
-265.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
-8.5%
Operating Margin
-9450.6%
Net Margin
-19122.2%
ROE
-36.5%
ROA
-104.0%
ROIC
-120.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2023 | $0.00 | NaN% | $-770.3K | $-100.3K | $-0.01 | — |
| FY 2023 | $176.0K | -8.5% | $-16.6M | $-33.7M | $-1.64 | — |
| Q3 2023 | $0.00 | NaN% | $-4.9M | $-4.6M | $-0.37 | — |
| Q2 2023 | $24.50 | -104.1% | $-2.3M | $-935.7K | $-0.04 | — |
| Q1 2023 | $24.50 | -104.1% | $-632.4K | $2.2M | $0.06 | — |
| Q4 2022 | $0.00 | NaN% | $-570.8K | $1.7M | $0.05 | — |
| FY 2022 | $0.00 | NaN% | $-1.7M | $2.3M | $0.06 | — |
| Q3 2022 | $0.00 | NaN% | $-258.0K | $1.1M | $0.03 | — |
| Q2 2022 | $0.00 | NaN% | $-344.8K | $-211.3K | $-0.01 | — |
| Q1 2022 | $0.00 | NaN% | $-516.0K | $-421.5K | $-0.01 | — |
| Q4 2021 | $0.00 | NaN% | $-187.3K | $-187.2K | $-0.01 | — |
| FY 2021 | $0.00 | NaN% | $-212.3K | $-212.2K | $-0.01 | — |